Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

New β-cells from old acini

Pancreatic acinar cells have been reprogrammed in vivo into insulin-expressing cells by adenoviral delivery of three transcription factors.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: An outline of the model used by Melton and colleagues1.

Katie Ris-Vicari

References

  1. 1

    Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D.A. Nature advance online publication, doi:10.1038/nature07314 (27 August 2008).

  2. 2

    Oliver-Krasinski, J.M. & Stoffers, D.A. Genes Dev. 22, 1998–2021 (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3

    D'Amour, K.A. et al. Nat. Biotechnol. 24, 1392–1401 (2006).

    CAS  Article  PubMed  Google Scholar 

  4. 4

    Ferber, S. et al. Nat. Med. 6, 568–572 (2000).

    CAS  Article  PubMed  Google Scholar 

  5. 5

    Heremans, Y. et al. J. Cell Biol. 159, 303–312 (2002).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6

    Slack, J.M. Nat. Rev. Mol. Cell. Biol. 8, 369–378 (2007).

    CAS  Article  PubMed  Google Scholar 

  7. 7

    Xu, X. et al. Cell 132, 197–207 (2008).

    CAS  Article  Google Scholar 

  8. 8

    Baeyens, L. et al. Diabetologia 48, 49–57 (2005).

    CAS  Article  PubMed  Google Scholar 

  9. 9

    Minami, K. et al. Proc. Natl. Acad. Sci. USA 102, 15116–15121 (2005).

    CAS  Article  PubMed  Google Scholar 

  10. 10

    Bouwens, L., Pipeleers, D.G. Diabetologia 41, 629–633 (1998).

    CAS  Article  PubMed  Google Scholar 

  11. 11

    Goldfine, I.D. et al. Nat. Biotechnol. 15, 1378–1382 (1997).

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Ethics declarations

Competing interests

M.S.G. is a Novocell, Inc., Scientific Advisory Board Member and stockholder. He is the inventor on six issued US patents pertaining to the delivery of genes to exocrine glands, one issued US patent for human Neurogenin3, and two issued US patents for the use of Neurogenin3 for the production of insulin-producing cells. All of these patents are held by the University of California.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

German, M. New β-cells from old acini. Nat Biotechnol 26, 1092–1093 (2008). https://doi.org/10.1038/nbt1008-1092

Download citation

Further reading

Search

Quick links